Tardive dyskinesia

This study tests whether valbenazine can reduce involuntary muscle movements (tardive dyskinesia) in adults who still have symptoms while taking or after stopping another similar drug. About 50 people with schizophrenia, bipolar disorder, or major depression will take valbenazine…

This study uses botulinum toxin (Botox) injections to treat movement disorders such as dystonia, tremor, and spasticity. Up to 2,000 participants aged 2 and older will receive tailored injections, with doctors trained in proper techniques. The goal is to manage symptoms and build…

This study tests a drug called deutetrabenazine for tardive dyskinesia (uncontrollable movements) in 25 adults with intellectual/developmental disabilities and psychiatric or behavioral disorders. Participants will take the medication for 24 weeks to see if it reduces movement pr…

This study tests an experimental drug, NBI-1065890, to see if it can reduce involuntary movements in adults with tardive dyskinesia, a condition often caused by long-term use of certain mental health medications. About 100 participants with schizophrenia, bipolar disorder, or dep…

This study tests whether a non-invasive brain stimulation method called rTMS can reduce the involuntary muscle spasms caused by long-term use of certain psychiatric medications. Researchers will use MRI scans to precisely target the stimulation in 62 adults with tardive dyskinesi…